NGEN

Nervgen Pharma Corp

• Dow Jones·6d ago

  NervGen Pharma Is Maintained at Buy by HC Wainwright & Co.

• Dow Jones·6d ago

  NervGen Pharma Price Target Cut to $15.00/Share From $18.00 by HC Wainwright & Co.

• TipRanks·07/14 10:00

  NervGen Pharma price target lowered to $15 from $18 at H.C. Wainwright

• Dow Jones·07/13 18:09

  NervGen Pharma Price Target Announced at $10.00/Share by Leerink Partners

• TipRanks·07/13 11:45

  NervGen Pharma initiated with an Outperform at Leerink

• Reuters·07/13 10:07

  NERVGEN PHARMA CORP <NGEN.O>: LEERINK PARTNERS INITIATES COVERAGE WITH OUTPERFORM RATING; PRICE TARGET $10

• Seeking Alpha·07/06 12:45

  United Therapeutics Vs. Regencell Bioscience: I Choose Profits Over Promises

• TipRanks·07/02 21:47

  NervGen Pharma Sets Up US$50 Million ATM Equity Program With Leerink Partners

• PUBT·07/02 21:24

  NervGen Pharma launches US$ 50 million at-the-market equity offering via Leerink Partners

• Seeking Alpha·07/02 16:25

  NervGen Pharma: I Think The Biggest Risks Are Now Behind It

• TipRanks·06/25 12:35

  H.C. Wainwright Reaffirms Their Buy Rating on NervGen Pharma (NGEN)

• Seeking Alpha·06/11 17:45

  NervGen rises as TD Cowen issues new Buy on lead asset

• TipRanks·06/11 13:46

  H.C. Wainwright Reaffirms Their Buy Rating on NervGen Pharma (NGEN)

• Reuters·06/11 10:06

  NERVGEN PHARMA CORP <NGEN.O>: TD COWEN INITIATES COVERAGE WITH BUY RATING

• TipRanks·06/11 09:51

  NervGen Pharma initiated with a Buy at TD Cowen